Company intelligence / Profile preview

Xianda Gene Technology

Suzhou, Jiangsu, Chinapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Xianda Gene Technology has developed proprietary isothermal nucleic acid amplification technologies enabling rapid (<15 min) on-site molecular diagnostics. Their "Gene Mirror" system integrates a portable fluorescence reader with a mobile app for real-time result upload and epidemic tracking. Products are used in food safety, animal health, and clinical molecular diagnostics. The company completed Pre-A financing in 2020 to expand innovation-driven operations.

Therapeutic areas: Infectious Diseases
Modalities: Nucleic acid detection technologyIsothermal amplificationDevice (miniature handheld fluorescence device)Mobile app-based diagnostics platform
Industry: Molecular Diagnostics

Partnerships

member unit of the National Health Industry Enterprise Management Association

Beyond the preview

Go deeper on Xianda Gene Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xianda Gene Technology.

Explore the full profile